Amura Technologies Overview

  • Year Founded
  • 1999

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 3

Amura Technologies General Information

Description

Designer of peptides. The company provides computational screening and design of small molecules to enable rapid identification of novel molecules for client companies.

Contact Information

Website
www.proteom.com
Formerly Known As
Proteom
Ownership Status
Acquired/Merged
Financing Status
Private Equity-Backed
Corporate Office
  • Babraham Hall
  • Babraham
  • Cambridge CB2 4AT
  • England, United Kingdom
Primary Industry
Biotechnology
Vertical(s)
Corporate Office
  • Babraham Hall
  • Babraham
  • Cambridge CB2 4AT
  • England, United Kingdom

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Amura Technologies Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Amura Technologies‘s full profile, request access.

Request a free trial

Amura Technologies Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Amura Technologies‘s full profile, request access.

Request a free trial

Amura Technologies FAQs

  • When was Amura Technologies founded?

    Amura Technologies was founded in 1999.

  • Where is Amura Technologies headquartered?

    Amura Technologies is headquartered in Cambridge, United Kingdom.

  • What industry is Amura Technologies in?

    Amura Technologies’s primary industry is Biotechnology.

  • Is Amura Technologies a private or public company?

    Amura Technologies is a Private company.

  • What is Amura Technologies’s current revenue?

    The current revenue for Amura Technologies is .

  • How much funding has Amura Technologies raised over time?

    Amura Technologies has raised $5.6M.

  • Who are Amura Technologies’s investors?

    Avlar BioVentures and Technomark Medical Ventures have invested in Amura Technologies.

  • When was Amura Technologies acquired?

    Amura Technologies was acquired on 06-Jan-2006.

  • Who acquired Amura Technologies?

    Amura Technologies was acquired by Amura (Drug Discovery).

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process